Showing results (21-30 of 69) with videos related to
Sort By:
Pageof 7
Anti-Cancer Drugs|February 1, 2007
Effects of camptothecin on tumor cell proliferation and angiogenesis when coupled to a bombesin analog used as a targeted delivery vectorLi-Chun Sun, Jing Luo, Vienna L Mackey, et al.Regulatory Peptides|June 2, 2005
Somatostatin inhibits insulin release via SSTR2 in hamster clonal beta-cells and pancreatic isletsCheng-Yu Yao, Manmeet Gill, Catherine A Martens, et al.Bioorganic & Medicinal Chemistry Letters|April 15, 2004
Examination of the 1,4-disubstituted azetidinone ring system as a template for combretastatin A-4 conformationally restricted analogue designLichun Sun, Natalya I Vasilevich, Joseph A Fuselier, et al.Oncotarget|April 21, 2017
Activated Notch signaling augments cell growth in hepatocellular carcinoma via up-regulating the nuclear receptor NR4A2Bo Zhu, Lichun Sun, Wei Luo, et al.Peptides|June 21, 2007
Vasoactive intestinal peptide-camptothecin conjugates inhibit the proliferation of breast cancer cellsTerry W Moody, Samuel A Mantey, Joseph A Fuselier, et al.Retina (Philadelphia, Pa.)|April 5, 2005
Study of inhibitory effects of an antiangiogenic somatostatin-camptothecin conjugate on laser-induced choroidal neovascularization in ratsYanno Bezerra, Joseph A Fuselier, Gholam A Peyman, et al.Diabetes|November 23, 2011
Somatostatin receptor type 2 antagonism improves glucagon and corticosterone counterregulatory responses to hypoglycemia in streptozotocin-induced diabetic ratsJessica T Y Yue, Elena Burdett, David H Coy, et al.Diabetes|February 26, 2013
Amelioration of hypoglycemia via somatostatin receptor type 2 antagonism in recurrently hypoglycemic diabetic ratsJessica T Y Yue, Michael C Riddell, Elena Burdett, et al.American Journal of Translational Research|March 8, 2018
HDAC inhibitors suppressed small cell lung cancer cell growth and enhanced the suppressive effects of receptor-targeting cytotoxins via upregulating somatostatin receptor IILichun Sun, Quanyong He, Cheguo Tsai, et al.Bioorganic & Medicinal Chemistry Letters|March 6, 2003
An adjustable release rate linking strategy for cytotoxin-peptide conjugatesJoseph A Fuselier, Lichun Sun, S Nathaniel Woltering, et al.Pageof 7